EG23204A - Process for the production of quinazolines. - Google Patents

Process for the production of quinazolines.

Info

Publication number
EG23204A
EG23204A EG2002070853A EG2002070853A EG23204A EG 23204 A EG23204 A EG 23204A EG 2002070853 A EG2002070853 A EG 2002070853A EG 2002070853 A EG2002070853 A EG 2002070853A EG 23204 A EG23204 A EG 23204A
Authority
EG
Egypt
Prior art keywords
quinazolines
production
Prior art date
Application number
EG2002070853A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG23204A publication Critical patent/EG23204A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
EG2002070853A 2001-08-01 2002-07-29 Process for the production of quinazolines. EG23204A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0118752.5A GB0118752D0 (en) 2001-08-01 2001-08-01 Process for the production of quinazolines

Publications (1)

Publication Number Publication Date
EG23204A true EG23204A (en) 2004-07-31

Family

ID=9919612

Family Applications (1)

Application Number Title Priority Date Filing Date
EG2002070853A EG23204A (en) 2001-08-01 2002-07-29 Process for the production of quinazolines.

Country Status (27)

Country Link
US (1) US7026479B2 (es)
EP (1) EP1412331B1 (es)
JP (1) JP2005501054A (es)
KR (1) KR20040019097A (es)
CN (1) CN1533378A (es)
AP (1) AP1299A (es)
AR (1) AR036204A1 (es)
AT (1) ATE323677T1 (es)
BR (1) BR0211670A (es)
CA (1) CA2451075A1 (es)
CZ (1) CZ2004151A3 (es)
DE (1) DE60210778T2 (es)
DO (1) DOP2002000443A (es)
EG (1) EG23204A (es)
ES (1) ES2260457T3 (es)
GB (1) GB0118752D0 (es)
HN (1) HN2002000197A (es)
HU (1) HUP0401573A3 (es)
IL (1) IL158998A0 (es)
MX (1) MXPA04000978A (es)
PA (1) PA8550301A1 (es)
PE (1) PE20030346A1 (es)
PL (1) PL368520A1 (es)
RU (1) RU2261861C1 (es)
UY (1) UY27399A1 (es)
WO (1) WO2003011829A1 (es)
ZA (1) ZA200309043B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1521747B1 (en) * 2002-07-15 2018-09-05 Symphony Evolution, Inc. Receptor-type kinase modulators and methods of use
ATE517091T1 (de) 2003-09-26 2011-08-15 Exelixis Inc C-met-modulatoren und verwendungsverfahren
JP4205757B2 (ja) 2004-05-06 2009-01-07 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 4−フェニルアミノ−キナゾリン−6−イル−アミド
AR063680A1 (es) * 2006-08-04 2009-02-11 Merz Pharma Gmbh & Co Kgaa Derivados de pirazolo[1, 5-a]pirimidina, metodos e intermediario para su preparacion, composiciones farmaceuticas que los comprenden y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades mediadas por la modulacion de mglur5.
KR102187034B1 (ko) 2009-01-16 2020-12-04 엑셀리시스, 인코포레이티드 암 치료용 n-(4-{〔6,7-비스(메틸옥시)퀴놀린-4-일〕옥시}페닐)-n'-(4-플루오로페닐)사이클로프로판-1,1-디카르복사미드의 말산염 및 그 결정형
JP5795304B2 (ja) 2009-03-18 2015-10-14 レスバーロジックス コーポレイション 新規抗炎症剤
IN2012DN00352A (es) * 2009-06-16 2015-08-21 Bikam Pharmaceuticals Inc
UA108618C2 (uk) 2009-08-07 2015-05-25 Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку
US9353063B2 (en) 2011-11-30 2016-05-31 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
RU2593752C1 (ru) * 2012-10-15 2016-08-10 Ресверлоджикс Корп. Соединения, пригодные для синтеза бензамидных соединений
CA2977308A1 (en) 2015-03-13 2016-09-22 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8719378D0 (en) * 1987-08-15 1987-09-23 Pfizer Ltd Antiarrythmic agents
US6069149A (en) * 1997-01-09 2000-05-30 Terumo Kabushiki Kaisha Amide derivatives and intermediates for the synthesis thereof

Also Published As

Publication number Publication date
HUP0401573A2 (hu) 2005-01-28
DOP2002000443A (es) 2003-02-15
EP1412331A1 (en) 2004-04-28
US20030100753A1 (en) 2003-05-29
PA8550301A1 (es) 2003-09-05
AP2002002602A0 (en) 2002-09-30
RU2261861C1 (ru) 2005-10-10
AP1299A (en) 2004-09-06
KR20040019097A (ko) 2004-03-04
EP1412331B1 (en) 2006-04-19
IL158998A0 (en) 2004-05-12
HUP0401573A3 (en) 2005-06-28
ZA200309043B (en) 2004-11-22
GB0118752D0 (en) 2001-09-26
WO2003011829A1 (en) 2003-02-13
AR036204A1 (es) 2004-08-18
UY27399A1 (es) 2003-02-28
DE60210778T2 (de) 2007-01-04
HN2002000197A (es) 2003-02-27
ES2260457T3 (es) 2006-11-01
RU2004102692A (ru) 2005-07-10
CN1533378A (zh) 2004-09-29
JP2005501054A (ja) 2005-01-13
PL368520A1 (en) 2005-04-04
US7026479B2 (en) 2006-04-11
PE20030346A1 (es) 2003-04-05
DE60210778D1 (de) 2006-05-24
ATE323677T1 (de) 2006-05-15
MXPA04000978A (es) 2004-04-20
CZ2004151A3 (cs) 2005-01-12
BR0211670A (pt) 2004-07-13
CA2451075A1 (en) 2003-02-13

Similar Documents

Publication Publication Date Title
MXPA03008041A (es) Proceso para la fabricacion de articulos moldeados.
MXPA03003302A (es) Proceso y compuestos intermedios para la produccion de anti-estrogenos 7-sustituidos.
MXPA03010020A (es) PROCEDIMIETO PARA LA PREPARACIoN DE UREA.
HUP0303590A3 (en) Method for the production of 4,6-diaminopyrimido[5,4-d]pyrimidines
GB2381524B (en) Process for the production of xylitol
GC0000309A (en) Process for the production of melamine
EG23204A (en) Process for the production of quinazolines.
EG23203A (en) Technical process for the manufacture of tropenol.
EG23439A (en) Olefins production process.
HUP0200567A3 (en) Process for the fermentative production of o-acetyl-serin
ZA200309472B (en) Process for the production of detergent granules.
AU9250401A (en) New process for the production of oxabispidines
TWI318975B (en) Process for the production of ethers
ZA200309943B (en) Process for the production of liquid hydrocarbons.
MXPA02006102A (es) Metodo para preparar compuestos bormodifluoroaceticos.
MXPA03008022A (es) Proceso para la produccion de polipeptidos.
MXPA02003042A (es) Proceso para prevenir formacion de incrustaciones.
PL366768A1 (en) Method for the production of improved pulp
GB0118935D0 (en) Xylanase production
AU2002335992A1 (en) Process for the production of ascopyrone p
MXPA03009210A (es) PROCEDIMIENTO PARA LA PREPARACIoN DE OXABISPIDINAS.
IL158119A0 (en) Method for the production of delta1-pyrrolines
HUP0401390A3 (en) Process for the manufacture of homopolyamide-4,6 fibers
PL366904A1 (en) Process for the continuous production of polyisocyanates
MXPA03007452A (es) Procesos para la produccion mejorada de pantotenato.